Endo Pharmaceuticals and BioDelivery Sciences announced that the FDA has approved Belbuca (buprenorphine) buccal film for use in patients with...
Collegium Pharmaceutical, Inc. and Biodelivery Sciences International, Inc. announced a definitive agreement pursuant to which Collegium will acquire BDSI for $5.60 per share in cash.
Endo International plc announced that it has entered into an agreement with its partner, BioDelivery Sciences International, Inc. (BDSI), to...
Endo Pharmaceuticals Inc. and BioDelivery Sciences International, Inc. presented pivotal data from two Phase III studies for investigational study drug...
BioDelivery Sciences International, Inc.( BDSI ) has announced that its Phase IIb clinical study assessing the efficacy and safety of...
Auxilium Pharmaceuticals, a subsidiary of Endo Pharma, has announced in a regulatory filing that it will terminate its licensing agreement...